BRAINTREE, MA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)BEAT CHILDHOOD CANCER FOUNDATION INC, founded in 2010, is a community nonprofit in the Medical Research sector that reported $1.6M in total revenue in fiscal year 2024. Revenue surged 31% from the prior year, signaling strong growth momentum. Expenses of $2.1M exceeded revenue, resulting in a 32% operating deficit.
BEAT CHILDHOOD CANCER DRIVES CHILDHOOD CANCER RESEARCH AND RAISES AWARENESS, MAKING A DIFFERENCE IN KIDS' SURVIVAL TODAY. OUR VISION IS TO CHANGE THE STORY FOR THE NEXT FAMILY BY FINDING VIABLE TREATMENTS AND ULTIMATELY, CURES FOR CHILDHOOD CANCERS.
BEAT CHILDHOOD CANCER DRIVES CHILDHOOD CANCER RESEARCH AND RAISES AWARENESS, MAKING A DIFFERENCE IN KIDS' SURVIVAL TODAY. THE ORGANIZATION AIMS TO CHANGE THE STORY FOR THE NEXT FAMILY BY FINDING...
BEAT CHILDHOOD CANCER DRIVES CHILDHOOD CANCER RESEARCH AND RAISES AWARENESS, MAKING A DIFFERENCE IN KIDS' SURVIVAL TODAY. THE ORGANIZATION AIMS TO CHANGE THE STORY FOR THE NEXT FAMILY BY FINDING VIABLE TREATMENTS AND ULTIMATELY, CURES FOR CHILDHOOD CANCERS. THE PRIMARY PURPOSE AND ACTIVITY OF BEAT CHILDHOOD CANCER IS TO RAISE FUNDS TO FACILITATE RESEARCH GRANTS TO BEAT CHILDHOOD CANCER RESEARCH CONSORTIUM.BEAT CHILDHOOD CANCER DRIVES PATIENT-AFFECTING CHILDHOOD CANCER CLINICAL TRIALS, EXPANDING HOW RESEARCH IS DONE. PRECISION MEDICINE IS THE FUTURE OF CANCER TREATMENT. WE ARE HELPING KIDS NOW WITH TARGETED THERAPIES AND ORAL DRUGS WITH LOW SIDE EFFECTS AIMED AT PREVENTING OR TREATING RELAPSE WITHOUT PUNITIVE, LONG-TERM SIDE EFFECTS. OUR COMMUNITY OF CLINICIANS, SCIENTISTS, PARENTS, AND SUPPORTERS HAVE BUILT AN INTERNATIONAL INFRASTRUCTURE AND TEAM OF RESEARCH AND CLINICAL COLLABORATORS TO ENSURE KIDS HAVE ACCESS TO THESE THERAPIES.SINCE 2010, OUR GROUP HAS OPENED NINETEEN CLINICAL TRIALS, DIRECTLY AFFECTING MORE THAN 1,000 KIDS. WHERE THE TRADITIONAL CLINICAL TRIAL MODEL OFTEN TAKES SEVERAL YEARS TO START ENROLLING PATIENTS, THE BEAT CHILDHOOD CANCER RESEARCH CONSORTIUM AIMS TO ENROLL CHILDREN ONCLINICAL TRIALS WITHIN ONE YEAR. OUR PATIENT-CENTERED FOCUS IS NOT BASED ON A SINGLE DOCTOR, HOSPITAL, OR DRUG. IT IS ABOUT HELPING EVERY CHILD, EVERYWHERE SURVIVE AND THRIVE FOLLOWING A CHILDHOOD CANCER DIAGNOSIS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $1,620,876 | $1,235,021 | +0.3% |
| Expenses | $2,137,389 | $1,854,383 | +0.2% |
| Net Income | $-516,513 | $-619,362 | -0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| PATRICK LACEY | PRESIDENT | 20.00 |
Officer
Director
|
$0 | $34,054 | $34,054 |
| ERIC CAISSE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MARK TAYLOR | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SARAH BARTOSZ | EXECUTIVE DIRECTOR | 40.00 |
Officer
|
$142,793 | $13,723 | $156,516 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $1,620,876 | $2,137,389 | $2,797,533 | $-516,513 |
| 2023 | $1,235,021 | $1,854,383 | $3,646,942 | $-619,362 |
| 2022 | $4,488,841 | $1,661,665 | $4,666,448 | $2,827,176 |
| 2021 | $1,628,336 | $1,909,225 | $1,950,018 | $-280,889 |
| 2020 | $2,162,103 | $1,419,421 | $1,871,646 | $742,682 |
| 2019 | $1,652,218 | $1,555,112 | $1,376,799 | $97,106 |
| 2018 | $1,118,299 | $1,194,923 | $989,693 | $-76,624 |
Compare BEAT CHILDHOOD CANCER FOUNDATION INC with other nonprofits in Massachusetts and across the country.